Search Within

Ana Alarcon Tomas

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (25)
  2. Journal Article (16)
  3. Research Letter (2)
  4. Correspondence (1)
Groups
  1. Bone Marrow Transplant (44)
  2. CTCR Scholars (44)
  3. Center for Hematologic Malignancies (44)
  4. Department of Medicine (44)
  5. Hematologic Malignancies, Division of (44)
  6. MSK Grad Students (44)

More Groups

People
  1. Miguel-Angel Perales (44)
  2. Michael Scordo (42)
  3. Gunjan Shah (41)
  4. Parastoo Dahi (39)
  5. Richard Lin (38)
  6. Maria Palomba (37)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (17)
  4. 2022 (10)
  5. 2021 (6)
  6. 2020 (2)

More Years

Publications
  1. Blood (17)
  2. Bone Marrow Transplantation (6)
  3. Transplantation and Cellular Therapy (5)
  4. Blood Advances (4)
  5. Hematological Oncology (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. Nature Publishing Group (9)
  3. Elsevier Inc. (7)
  4. Wiley Blackwell (2)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (44)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation
    Journal Article

    Sanchez-Escamilla, M.; Flynn, J.; Devlin, S.; Maloy, M.; Fatmi, S. A.; Tomas, A. A.; Escribano-Serrat, S.; Ponce, D.; Sauter, C. S.; Giralt, S. A.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury in large cell lymphoma patients receiving CD19 CAR T cell therapy
    Meeting Abstract

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Tomas, A. A.; Fein, J. A.; Slingerland, J.; Parascondola, A.; Lin, R. J.; Scordo, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Inflammatory biomarker clusters are predictive of response and toxicity in large B-cell lymphoma treated with CD19 CAR-T cell therapy
    Meeting Abstract

    Raj, S.; Perales, M. A.; Fein, J. A.; Tomas, A. A.; Batlevi, C. L.; De Lapuerta, M. C.; Dahi, P. B.; Danylesko, I.; Fried, S.; Funnell, T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Management of prolonged cytopenia following CAR T-cell therapy
    Correspondence

    Corona, M.; Shouval, R.; Alarcón, A.; Flynn, J.; Devlin, S.; Batlevi, C.; Mantha, S.; Palomba, M. L.; Scordo, M.; Shah, G.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Vitamin D insufficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Journal Article

    Nath, K.; Tomas, A. A.; Flynn, J.; Fein, J. A.; Alperovich, A.; Anagnostou, T.; Batlevi, C. L.; Dahi, P. B.; Fingrut, W. B.; Giralt, S. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Patterns of relapse and risk reduction following tumor debulking by bridging radiotherapy prior to chimeric antigen receptor T cell therapy in non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Michaud, L.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Alarcon Tomas, A.; Shouval, R.; Palomba, M. L.; Batlevi, C. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Radiotherapy for relapse after chimeric antigen receptor T cell therapy in hematologic malignancies
    Meeting Abstract

    Hubbeling, H. G.; Silverman, E. A.; Alarcon Tomas, A.; Tringale, K. R.; Wijetunga, N. A.; Hajj, C.; Mailankody, S.; Batlevi, C. L.; Dahi, P. B.; Giralt, S. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save